Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 363,773 | 436,086 | 0 | N/A |
| Marketable Securities | 182,220 | N/A | 0 | N/A |
| Receivables | 2,845 | N/A | 0 | N/A |
| TOTAL | $568,622 | $445,223 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 5,625 | 1,575 | 0 | N/A |
| Investments And Advances | 31,144 | 17,050 | 0 | 0 |
| Other Non-Current Assets | 26,288 | 1,093 | 0 | 0 |
| TOTAL | $63,057 | $19,718 | $N/A | $N/A |
| Total Assets | $631,679 | $464,941 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,852 | 13,509 | 0 | 0 |
| Accrued Expenses | 36,435 | 14,731 | 0 | N/A |
| Other current liabilities | 4,078 | 3,009 | 0 | N/A |
| TOTAL | $60,385 | $32,577 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 91,791 | 54,507 | 0 | N/A |
| Other Non-Current Liabilities | 33,768 | 39,319 | 13,267 | 0 |
| TOTAL | $97,561 | $55,124 | $N/A | $N/A |
| Total Liabilities | $157,946 | $87,701 | $0 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 123,766 | N/A | N/A | N/A |
| Common Shares | 124 | 92 | 0 | N/A |
| Retained earnings | -440,031 | -179,444 | 0 | N/A |
| Other shareholders' equity | 65,533 | 62,361 | 0 | 0 |
| TOTAL | $473,733 | $377,240 | $0 | $N/A |
| Total Liabilities And Equity | $631,679 | $464,941 | $0 | $0 |